top of page
News
April 2019
Incorporation of Synendos Therapeutics AG
March 2019
Synendos Therapeutics was selected for Venture Leaders in Life Sciences programme 2019 (9-15 June, Boston, USA)
January 2019
Synendos Therapeutics won BaseLaunch Phase II and was awarded with CHF 240'000
December 2018
Synendos Therapeutics wins Venture Kick Stage I (CHF 10'000)
November 2018
Synendos selected for Innosuisse initial start-up program
September 2019
Synendos Therapeutics was selected for BaseLaunch Phase I (CHF 10'000)
bottom of page